The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in ...

The FDA granted orphan drug designation to a CAR T-cell therapy for recurrent glioblastoma and high-grade astrocytomas.

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.

Cancer is nonpartisan. It touches everyone — cutting across religion, race, ethnicity, sexual orientation and socioeconomic ...

Zac Mirecki reflects on six years of survivorship, sharing how his AML journey taught him to priori-tize self-care, seek ...

Learning I carried the BRCA1 mutation was terrifying, but it gave me the power to choose prevention, embrace survivorship, ...

Fear is a powerful enemy of the mind but there’s another word that has the same power. That word is a six letter one, cancer.

Multidisciplinary care, a collaborative approach where various healthcare disciplines come together, is essential for treating those with prostate cancer.

Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia ...

Key Takeaways Tumor-infiltrating lymphocyte (TIL) therapy offers a novel approach for advanced melanoma, leveraging the patient's immune system for treatment-resistant cases. The FDA approved a ...

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.

The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.